265 results on '"Bedane, Christophe"'
Search Results
2. Gliptin-induced bullous pemphigoid: withdrawal of gliptin allows for faster control of the disease
3. Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib
4. Pemphigus vegetans following intravesical Bacillus Calmette-Guerin: a first case report
5. Nivolumab-induced multiple morphea associated with eosinophilic fasciitis
6. Boletus dermatitis: first report in France of flagellate erythema after consumption of Porcini mushrooms
7. Large International Validation of ABSIS and PDAI Pemphigus Severity Scores
8. STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network
9. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
10. PD-1 inhibitors might limit the development of brain metastases in patients with advanced melanoma
11. Author Correction: B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid
12. B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid
13. Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.
14. Efficacity and safety of dupilumab in bullous pemphigoid: a retrospective multicentric study of 36 patients
15. Efficacy of imiquimod in the management of lentigo maligna
16. Severe and refractory solar urticaria treated with intravenous immunoglobulins: A phase II multicenter study
17. Methotrexate is safe and effective as long-term treatment for bullous pemphigoid
18. Traitements locorégionaux des sites métastatiques chez des patients atteints d’un mélanome pauci-métastatique (hors métastase cérébrale) : recommandations nationales françaises
19. Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids
20. Anti‐BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis.
21. Incidence and Mortality of Bullous Pemphigoid in France
22. Incidence and severity of COVID-19 in patients with autoimmune blistering skin diseases: A nationwide study
23. Solar urticaria treated with intravenous immunoglobulins
24. Risk Factors for Bullous Pemphigoid in the Elderly: A Prospective Case–Control Study
25. A nationwide study evaluating the association of autoimmune bullous diseases and acquired haemophilia: description of clinical and prognostic features
26. Pemphigoïde cicatricielle, pemphigoïde des muqueuses
27. Unusual cutaneous manifestations of late Lyme borreliosis
28. Incidence and severity of COVID-19 in patients with autoimmune blistering skin diseases: A nationwide study
29. Localisation inhabituelle et méconnue de métastases de mélanome : métastases bilatérales des conduits auditifs internes
30. Intérêt de l’omalizumab dans le traitement de la pemphigoïde bulleuse
31. Étude comparative de la mortalité des patients atteints de pemphigus selon l’utilisation du rituximab ou de traitements conventionnels
32. Musculoskeletal Symptoms in Patients With Cryopyrin-Associated Periodic Syndromes: A Large Database Study
33. A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study
34. B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses
35. Annular lipoatrophy of the ankle: Four new pediatric cases and a review of the literature
36. Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group
37. Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy
38. A single cycle of rituximab for the treatment of severe pemphigus
39. Clinical and Immunologic Factors Associated With Bullous Pemphigoid Relapse During the First Year of Treatment: A Multicenter, Prospective Study
40. Prevalence and Clinical Significance of Anti–Laminin 332 Autoantibodies Detected by a Novel Enzyme-Linked Immunosorbent Assay in Mucous Membrane Pemphigoid
41. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid
42. Predictive Factors of Non-Response to Vismodegib in Locally Advanced Basal-Cell Carcinoma
43. A case of verrucous carcinoma of the back in a 17 year old immunocompetent
44. Efficacy of imiquimod in the management of lentigo maligna.
45. Onset of Psoriatic Arthritis in Patients Treated With Efalizumab for Moderate to Severe Psoriasis
46. Prospective Multicenter Study of Pegylated Liposomal Doxorubicin Treatment in Patients With Advanced or Refractory Mycosis Fungoides or Sézary Syndrome
47. Incidence and Mortality of Pemphigus in France
48. Comparison of Topical Methyl Aminolevulinate Photodynamic Therapy With Cryotherapy or Fluorouracil for Treatment of Squamous Cell Carcinoma In Situ: Results of a Multicenter Randomized Trial
49. Generalized Eczema Craquele as a Presenting Feature of Systemic Lymphoma: Report of Seven Cases
50. Treatment of Refractory Pemphigus Vulgaris With Rituzimab (Anti-CD20 Monoclonal Antibody)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.